Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Lynwood, California Clinical Trials

A listing of Lynwood, California clinical trials actively recruiting patient volunteers.

RESULTS

Found (929) clinical trials

Safety Follow-up Study in Subjects With Silicone Gel-filled Breast Implants as Compared Both to Saline-filled Breast Implants and to National Norms

Ten year safety study examining rates of rare adverse events, child bearing issues, effects of mammography, MRI compliance and results, and long-term benefit of silicone-filled breast implants.

Phase N/A

3.6 miles

Learn More »

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US

Healthy infants will be enrolled and randomized to receive either 4 doses of MenACYW conjugate vaccine or 4 doses of the licensed control vaccine, MENVEO. All participants will receive routine vaccines as per the Advisory Committee on Immunization Practices (ACIP) recommendations. All participants will be assessed for immunogenicity at baseline ...

Phase

3.6 miles

Learn More »

Study to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine Given With Prevnar 13 in Healthy Infants

This is a Phase 2, randomized, active-controlled, open-label study with a 3-arm parallel design. Healthy 2-month old infants (42 to 98 days of age) with no history of pneumococcal vaccination will be randomized in a 1:1:1 ratio to receive a 4-dose series of: multivalent pneumococcal conjugate vaccine coadministered with Prevnar ...

Phase

3.6 miles

Learn More »

A Study to Evaluate the Safety Tolerability and Immunogenicity of V114 When Administered Concomitantly With Influenza Vaccine in Healthy Adults 50 Years of Age or Older (V114-021/PNEU-FLU)

This study is designed to evaluate the safety and tolerability of a single dose of V114 when administered concomitantly and non-concomitantly (i.e., 30 days after) with influenza vaccine. It will also evaluate whether V114 can be administered concomitantly with influenza vaccine without impairing the antibody responses to the 15 serotypes ...

Phase

3.6 miles

Learn More »

You or your child may be experiencing Bacterial Conjunctivitis, commonly known as Pink eye. To see if you or your child may qualify to take part in a clinical research study of an investigational eye drop compared to placebo (an inactive substance) - contact a participating local physician. Pink Eye ...

Phase

3.6 miles

Learn More »

Did you know? Meningococcal germs are the common causes of serious blood infections and meningitis (serious brain infection), which could lead to brain damage, hearing loss, and learning disabilities. The SHINE study was created to find out how a new vaccine for meningococcal disease will work for children, adolescents, and ...

Phase N/A

3.6 miles

Learn More »

If you are age 65 or over and suffer from symptoms of overactive bladder (OAB), you may be interested in a research study we are conducting to evaluate an approved medication for overactive bladder. If you take part in this research study, you will attend five office visits over a ...

Phase N/A

3.6 miles

Learn More »

Are you at least 40 years of age? Do you have trouble breathing or a persistent cough? You may have a disease called Chronic Obstructive Pulmonary Disease or COPD. A clinical research study on an investigational inhaled medication is being conducted at: Center for Clinical Trials. If you currently smoke ...

Phase N/A

3.6 miles

Learn More »

We know it can be difficult to find the right medicine to keep you blood sugar in your target range. We are currently testing a potential new medicine for type 2 diabetes that can be taken in addition to your current metformin treatment. Clinical Study Enrolling Patients Now! You may ...

Phase N/A

3.6 miles

Learn More »

Center for Clinical Trials,LLC is seeking volunteers to join a research study evaluating an investigational study drug for the treatment of Type 2 Diabetes Mellitus. To learn more, please call

Phase N/A

3.6 miles

Learn More »